Gut microbiota and their metabolites in the progression of non-alcoholic fatty liver disease

Non-alcoholic fatty liver disease (NAFLD) is the most prevalent liver disorder worldwide. It comprises a spectrum of conditions that range from steatosis to non-alcoholic steatohepatitis, with progression to cirrhosis and hepatocellular carcinoma. Currently, there is no FDA-approved pharmacological...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Jin, Tripathi, Madhulika, Sinha, Rohit A., Singh, Brijesh Kumar, Yen, Paul M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7116620/
https://www.ncbi.nlm.nih.gov/pubmed/33490737
http://dx.doi.org/10.20517/2394-5079.2020.134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7116620/
https://www.ncbi.nlm.nih.gov/pubmed/33490737
http://dx.doi.org/10.20517/2394-5079.2020.134

Ejemplares similares